Triune Financial Partners, LLC Pfizer Inc Transaction History

Triune Financial Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Nov 14, 2024	SELL	$26.13 - $33.94 $247,555 - $321,547	-9,474 Closed	0 $0
Q3 2023 Nov 14, 2024	BUY	$32.09 - $37.51 $304,020 - $355,369	9,474 New	9,474 $314 Million
Q2 2023 Dec 06, 2024	BUY	$36.12 - $41.79 $340,250 - $393,661	9,420 New	9,420 $346 Million
Q4 2022 Dec 06, 2024	SELL	$41.75 - $54.5 $33,149 - $43,273	-794 Reduced 14.47%	4,692 $240 Million
Q3 2022 Dec 06, 2024	BUY	$43.76 - $53.42 $2,056 - $2,510	47 Added 0.86%	5,486 $240 Million
Q2 2022 Dec 06, 2024	BUY	$46.53 - $55.17 $1,861 - $2,206	40 Added 0.74%	5,439 $285 Million
Q1 2022 Dec 06, 2024	BUY	$45.75 - $56.69 $247,004 - $306,069	5,399 New	5,399 $280 Million
Q4 2021 Dec 06, 2024	BUY	$41.32 - $61.25 $3,429 - $5,083	83 Added 1.57%	5,354 $316 Million
Q2 2021 Dec 06, 2024	BUY	$35.91 - $40.68 $189,281 - $214,424	5,271 New	5,271 $206 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Triune Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Triune Financial Partners, LLC with notifications on news.